Protagenic Therapeutics, Inc.\new - FORM 8-K - EX-99.1 - EXHIBIT 99.1 - May 26, 2017

Attached files

file filename
8-K - FORM 8-K - Protagenic Therapeutics, Inc.\newatrn20170525_8k.htm

Exhibit 99.1

 

 

 

 
 
 

 

 

 

 
 
 

 

 

 

 
 
 

 

 

 

 
 
 

 

BOARD OF DIRECTORS

 

Garo H. Armen, PhD

Executive Chairman
Nominating and Corporate Governance Committee
Science Committee

 

Robert B. Stein, PhD

Science Committee (Chairperson)
Nominating and Corporate Governance Committee

 

Khalil Barrage
Compensation Committee (Chairperson)

Audit Committee

 

Gregory H. Ekizian

Audit Committee (Chairperson)

Compensation Committee

 

Joshua Silverman
Nominating and Corporate Governance Committee (Chairperson)
Compensation Committee
Science Committee

SENIOR MANAGEMENT

 

 

Garo H. Armen, PhD
Executive Chairman

 

Alexander K. Arrow, MD, CFA
Chief Financial Officer

 

David Lovejoy, PhD

Chief Scientific Advisor

 

Dalia Barsyte, PhD

Chief Technology Advisor

 

 

STOCKHOLDER INFORMATION

 

Corporate Headquarters:

 

Protagenic Therapeutics, Inc.
149 Fifth Avenue, Suite 500
New York, NY 10010
(212) 994-8202
www.protagenic.com

Transfer Agent:

 

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(718) 921-8200
www.astfinancial.com

 

Independent Auditors:

 

MaloneBailey, LLP
9801 Westheimer Rd., Suite 1100
Houston, TX 77042
(713) 343-4267
www.malonebailey.com

 

Protagenic Therapeutics, Inc.\new Reports